Abstract
Human PBL incubated in vitro with the new anti-rheumatic drug triethylphosphine gold (Auranofin) show a rapid concentration-dependent increase in NK reactivity to a variety of targets (Raji, K-562, HAE 70). The process is not affected by major changes in the proportion of monocytes present and is only slightly affected by actinomycin D or cycloheximide. In contrast to TPG, the effect of interferon is to boost the activity of K cells as well as NK cells, and this boost appears to be more sensitive to inhibition of protein or RNA synthesis. These factors suggest that TPG may be working through a different mechanism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Herberman R. R., Ortaldo J. R., Bonnard G. D. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature. 1979 Jan 18;277(5693):221–223. doi: 10.1038/277221a0. [DOI] [PubMed] [Google Scholar]
- Ortaldo J. R., Phillips W., Wasserman K., Herberman R. B. Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. J Immunol. 1980 Oct;125(4):1839–1844. [PubMed] [Google Scholar]
- Russell A. S., Davis P., Miller C. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity. J Rheumatol. 1982 Jan-Feb;9(1):30–35. [PubMed] [Google Scholar]